Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAshmore Group Regulatory News (ASHM)

Share Price Information for Ashmore Group (ASHM)

Share Price is delayed by 15 minutes
Get Live Data
203.00    0.40 (0.20%)
Bid:
202.40
Ask:
203.40
Spread: 1.00 (0.494%)
Market Cap: £1.32b
ASHM Live PriceLast checked at - London Stock Exchange

Intraday Ashmore Group Share Chart

Trading Statement

16 Jul 2009 07:00

RNS Number : 7555V
Ashmore Group PLC
16 July 2009
 



 Ashmore Group plc

+0700 16 July 2009 

TRADING UPDATE AND ASSETS UNDER MANAGEMENT sTATEMENT

Ashmore Group plc ("Ashmore", the "Group"), a leading specialist emerging markets asset manager, announces the following trading update and Assets under Management ("AuM") statement in respect of the period ended 30 June 2009.

Assets under Management

Actual 

Estimated 

Estimated

Theme

31 March

2009

(US$ billion)

30 June

2009

(US$ billion)

Movement

Q3vsQ4

(%)

External Debt 

14.4

16.0

+11%

Local Currency

4.6

4.5

-2%

Special Situations

4.4

4.3

-2%

Equity

0.1

0.1

-

Total

23.5

24.9

+6%

The final quarter of the financial year ended 30 June 2009 saw AuM increase by US$1.4 billion (6%) to US$24.9 billion. This increase comprises investment performance of US$1.9 billion, arising in external debt and local currency, partially offset by net redemptions of US$0.5 billion, solely within the local 

currency theme.

During the financial year ended 30 June 2009, AuM decreased to US$24.9 billion from US$37.5 billion. Investment performance was US$5.1 billion adverseUS$7.1 billion adverse in the first half, and US$2.0 billion positive in the second half. Neredemptions in the period were US$7.4 billion, of which US$5.7 billion arose in the first half of the year across all themes, largely reflecting the liquidity needs of our clients in the extreme market conditions. Over the second half, redemptions have slowed significantly, while subscription levels have begun to increase within both public funds and segregated mandates, with net subscriptions achieved in May and June.  

The expansion of the average revenue margin experienced in the first half, principally because of the AuM mix, has been impacted by the timing and make up of external debt and local currency redemptions at the back end of the first half, and through the second half. This has resulted in the average revenue margin for the final quarter returning to the FY07/08 level of 103bps.  

The results for the full year ended 30 June 2009 are in-line with management expectations in the current operating environment. The loss for the year in respect of FX hedge contracts is £42.8 million (6 months to 31 December 2008: £54.2 million)of which £4.5 million (6 months to 31 December 2008: £12.7 million) relates to the mark-to-market of forward contracts to partially hedge FY09/10 management fees. These FY09/10 forward contracts have an aggregate notional value 

of US$120 million, marked at the year end rate of GBP1:1.6458USD. Any future gains or losses on these contracts will arise from deviations from this year end rate.

The Group will announce its results in respect of the financial year to 30 June 2009 on 

15 September 2009. There will be a presentation for analysts at 0900 on that date at the offices of Goldman Sachs at Peterborough Court133 Fleet Street London EC4A 2BB. A copy of the presentation will be made available on the Group's website at www.ashmoregroup.com.

For further information, please contact:

Ashmore Group plc

Graeme Dell, Group Finance Director +44 (0)20 3077 6000

Penrose Financial  +44(0)20 7786 4888 

Gay Collins +44(0)7798 626282

Ashmore@penrose.co.uk 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTIFFVLDEIELIA
Date   Source Headline
14th Aug 20185:16 pmRNSHolding(s) in Company
13th Jul 20187:00 amRNSTrading Statement
2nd Jul 20188:44 amRNSDirectorate Change
20th Apr 20184:30 pmRNSDirector/PDMR Shareholding
17th Apr 20187:00 amRNSTrading Statement
4th Apr 20184:32 pmRNSDirector/PDMR Shareholding
29th Mar 20184:00 pmRNSDirector/PDMR Shareholding
8th Feb 20187:00 amRNSHalf-year Report
16th Jan 20187:00 amRNSTrading Statement
6th Dec 20171:55 pmRNSDirectorate Change
5th Dec 201711:45 amRNSDirector/PDMR Shareholding
5th Dec 201710:57 amRNSDirector/PDMR Shareholding
20th Oct 20173:08 pmRNSResult of AGM
13th Oct 20174:49 pmRNSDirector/PDMR Shareholding
13th Oct 20177:00 amRNSTrading Statement
19th Sep 20172:11 pmRNSDirector/PDMR Shareholding
19th Sep 20172:07 pmRNSDirector/PDMR Shareholding
7th Sep 20177:00 amRNSFinal Results
14th Jul 20177:00 amRNSTrading Statement
16th Jun 20177:00 amRNSInvestor presentation
21st Apr 20174:30 pmRNSDirector/PDMR Shareholding
18th Apr 20177:00 amRNSTrading Statement
10th Apr 20175:19 pmRNSDirector/PDMR Shareholding
29th Mar 20179:23 amRNSHolding(s) in Company
28th Mar 20174:54 pmRNSDirector/PDMR Shareholding
9th Feb 20177:00 amRNSHalf-year Report
16th Jan 20177:00 amRNSTrading Statement
21st Oct 20163:57 pmRNSResult of AGM
14th Oct 20167:00 amRNSTrading Statement
21st Sep 20164:30 pmRNSDirector/PDMR Shareholding
21st Sep 20164:30 pmRNSDirector/PDMR Shareholding
6th Sep 20167:00 amRNSFinal Results
10th Aug 201610:45 amRNSHolding(s) in Company
14th Jul 20167:00 amRNSTrading Statement
18th May 201610:00 amRNSAppointment of joint corporate broker
20th Apr 20164:28 pmRNSHolding(s) in Company
19th Apr 20167:00 amRNSTrading Statement
15th Apr 20164:39 pmRNSHolding(s) in Company
4th Apr 20168:56 amRNSDirector/PDMR Shareholding
24th Mar 20165:30 pmRNSDirector/PDMR Shareholding
23rd Mar 20168:21 amRNSHolding(s) in Company
11th Feb 20167:00 amRNSHalf Yearly Report
14th Jan 20167:00 amRNSTrading Statement
11th Dec 20155:30 pmRNSDirector/PDMR Shareholding
11th Dec 20155:28 pmRNSDirectorate Change
7th Dec 201510:13 amRNSDirector/PDMR Shareholding
13th Nov 20159:15 amRNSDirector/PDMR Shareholding
28th Oct 201511:56 amRNSForm 8.3 - Al Noor Hospitals Group PLC
28th Oct 201511:52 amRNSForm 8.3 - NMC Health plc
27th Oct 20154:42 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.